By AMY DOCKSER MARCUS CLAREMONT, Calif.—Staff members at the Food and Drug Administration are doing something unusual. They are leaving Washington to help drug makers take a crucial step in developing drugs for rare diseases. View Full Image Hempel Family Twins Addison, left, and Cassidy Hempel, who have a fatal cholesterol metabolism disorder, get cyclodextrin infusions April 13 in Reno, Nev. The staffers help administer the Orphan Drug Act, which provides incentives to create therapies...
Full Story: Wall Street Journal
